Phase 1/2 Dose-Escalation/Dose-Expansion Study of Anti-CD7 Allogeneic CAR-T Cells (WU-CART-007) in Relapsed or Refractory (R/R) T-Cell Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma (T-ALL/LBL)
Authors:
- Armin GhobadiAGArmin Ghobadi
- Ibrahim AldossIAIbrahim Aldoss
- Shannon L. MaudeSMShannon L. Maude
- Deepa BhojwaniDBDeepa Bhojwani
- Alan S. WayneAWAlan S. Wayne
- Ashish BajelABAshish Bajel
- Dholaria BhagirathbhaiDBDholaria Bhagirathbhai
- Rawan G FaramandRFRawan G Faramand
- Ryan J. MattisonRMRyan J. Mattison
- Michael P. RettigMRMichael P. Rettig
- Kenneth JacobsKJKenneth Jacobs
- Ouiam BakkachaOBOuiam Bakkacha
Open Access
- 7 February 2024
- journal article
- abstracts
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 30 (2) , S14-S15